Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2004 Feb;13(1):13–19. doi: 10.1080/09629350410001664806

Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats.

Aluet Borrego 1, Zullyt B Zamora 1, Ricardo González 1, Cheyla Romay 1, Silvia Menéndez 1, Frank Hernández 1, Teresita Montero 1, Enys Rojas 1
PMCID: PMC1781537  PMID: 15203559

Abstract

BACKGROUND: Acute renal failure is a dose-limiting factor of cisplatin chemotherapy. Here, we show the protective effect of ozone oxidative preconditioning against cisplatin-induced renal dysfunction in rats. Ozone oxidative preconditioning is a prophylactic approach, which favors the antioxidant-pro-oxidant balance for preservation of the cell redox state by increasing antioxidant endogenous systems in various in vivo and in vitro experimental models. AIMS: To analyze the protective role of ozone oxidative preconditioning against cisplatin-induced nephrotoxicity. METHODS: Male Sprague-Dawley rats were pretreated with 15 intrarectal applications of ozone/oxygen mixture at 0.36, 0.72, 1.1, 1.8 and 2.5 mg/kg before cisplatin intraperitoneal injection (6 mg/kg). Serum and kidneys were extracted and analyzed 5 days after cisplatin treatment for determinations of the renal content of glutathione, thiobarbituric acid-reactive substances, renal concentration and enzymatic activities of catalase, superoxide dismutase and glutathione peroxidase. RESULTS: Ozone pretreatment prevented the increase in serum creatinine levels, the glutathione depletion and the inhibition of superoxide dismutase, catalase and glutathione peroxidase activities induced by cisplatin in the rat kidney. Also, the renal content of thiobarbituric acid-reactive substances was decreased by ozone therapy. These protective effects of ozone were dose dependent. CONCLUSIONS: Intrarectal ozone therapy prevented effectively the renal antioxidant unbalance induced by cisplatin treatment.

Full Text

The Full Text of this article is available as a PDF (242.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Gayoum A. A., El-Jenjan K. B., Ghwarsha K. A. Hyperlipidaemia in cisplatin-induced nephrotic rats. Hum Exp Toxicol. 1999 Jul;18(7):454–459. doi: 10.1191/096032799678840255. [DOI] [PubMed] [Google Scholar]
  2. Appenroth D., Fröb S., Kersten L., Splinter F. K., Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997;71(11):677–683. doi: 10.1007/s002040050444. [DOI] [PubMed] [Google Scholar]
  3. BEUTLER E., DURON O., KELLY B. M. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963 May;61:882–888. [PubMed] [Google Scholar]
  4. Babu E., Gopalakrishnan V. K., Sriganth I. N., Gopalakrishnan R., Sakthisekaran D. Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem. 1995 Mar 9;144(1):7–11. doi: 10.1007/BF00926734. [DOI] [PubMed] [Google Scholar]
  5. Baliga R., Ueda N., Walker P. D., Shah S. V. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997 Mar;29(3):465–477. doi: 10.1016/s0272-6386(97)90212-2. [DOI] [PubMed] [Google Scholar]
  6. Barber E., Menéndez S., León O. S., Barber M. O., Merino N., Calunga J. L., Cruz E., Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediators Inflamm. 1999;8(1):37–41. doi: 10.1080/09629359990702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blöchl-Daum B., Pehamberger H., Kurz C., Kyrle P. A., Wagner O., Müller M., Monitzer B., Eichler H. G. Effects of cisplatin on urinary thromboxane B2 excretion. Clin Pharmacol Ther. 1995 Oct;58(4):418–424. doi: 10.1016/0009-9236(95)90055-1. [DOI] [PubMed] [Google Scholar]
  8. Brady H. R., Kone B. C., Stromski M. E., Zeidel M. L., Giebisch G., Gullans S. R. Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am J Physiol. 1990 May;258(5 Pt 2):F1181–F1187. doi: 10.1152/ajprenal.1990.258.5.F1181. [DOI] [PubMed] [Google Scholar]
  9. Davis C. A., Nick H. S., Agarwal A. Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001 Dec;12(12):2683–2690. doi: 10.1681/ASN.V12122683. [DOI] [PubMed] [Google Scholar]
  10. Dobyan D. C., Levi J., Jacobs C., Kosek J., Weiner M. W. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther. 1980 Jun;213(3):551–556. [PubMed] [Google Scholar]
  11. Faraji B., Kang H. K., Valentine J. L. Methods compared for determining glutathione peroxidase activity in blood. Clin Chem. 1987 Apr;33(4):539–543. [PubMed] [Google Scholar]
  12. Hernández F., Menéndez S., Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med. 1995 Jul;19(1):115–119. doi: 10.1016/0891-5849(94)00201-t. [DOI] [PubMed] [Google Scholar]
  13. Husain K., Morris C., Whitworth C., Trammell G. L., Rybak L. P., Somani S. M. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem. 1998 Jan;178(1-2):127–133. doi: 10.1023/a:1006889427520. [DOI] [PubMed] [Google Scholar]
  14. Ikeda S., Fukuzaki A., Kaneto H., Ishidoya S., Orikasa S. Role of protein kinase C in cisplatin nephrotoxicity. Int J Urol. 1999 May;6(5):245–250. doi: 10.1046/j.1442-2042.1999.00058.x. [DOI] [PubMed] [Google Scholar]
  15. Lau A. H. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int. 1999 Oct;56(4):1295–1298. doi: 10.1046/j.1523-1755.1999.00687.x. [DOI] [PubMed] [Google Scholar]
  16. Lebwohl D., Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer. 1998 Sep;34(10):1522–1534. doi: 10.1016/s0959-8049(98)00224-x. [DOI] [PubMed] [Google Scholar]
  17. León O. S., Menéndez S., Merino N., Castillo R., Sam S., Pérez L., Cruz E., Bocci V. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm. 1998;7(4):289–294. doi: 10.1080/09629359890983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Marklund S. L. Properties of extracellular superoxide dismutase from human lung. Biochem J. 1984 May 15;220(1):269–272. doi: 10.1042/bj2200269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matsushima H., Yonemura K., Ohishi K., Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med. 1998 Jun;131(6):518–526. doi: 10.1016/s0022-2143(98)90060-9. [DOI] [PubMed] [Google Scholar]
  20. Minami M., Yoshikawa H. A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta. 1979 Mar 15;92(3):337–342. doi: 10.1016/0009-8981(79)90211-0. [DOI] [PubMed] [Google Scholar]
  21. Murry C. E., Richard V. J., Reimer K. A., Jennings R. B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990 Apr;66(4):913–931. doi: 10.1161/01.res.66.4.913. [DOI] [PubMed] [Google Scholar]
  22. Nath K. A., Norby S. M. Reactive oxygen species and acute renal failure. Am J Med. 2000 Dec 1;109(8):665–678. doi: 10.1016/s0002-9343(00)00612-4. [DOI] [PubMed] [Google Scholar]
  23. Neschis D. G., Safford S. D., Raghunath P. N., Langer D. J., David M. L., Hanna A. K., Tomaszewski J. E., Kariko K., Barnathan E. S., Golden M. A. Thermal preconditioning before rat arterial balloon injury: limitation of injury and sustained reduction of intimal thickening. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):120–126. doi: 10.1161/01.atv.18.1.120. [DOI] [PubMed] [Google Scholar]
  24. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979 Jun;95(2):351–358. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
  25. Peralta C., León O. S., Xaus C., Prats N., Jalil E. C., Planell E. S., Puig-Parellada P., Gelpí E., Roselló-Catafau J. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res. 1999 Sep;31(3):191–196. doi: 10.1080/10715769900300741. [DOI] [PubMed] [Google Scholar]
  26. Peralta C., Xaus C., Bartrons R., Leon O. S., Gelpi E., Roselló-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic Res. 2000 Nov;33(5):595–605. doi: 10.1080/10715760000301121. [DOI] [PubMed] [Google Scholar]
  27. Riepe M. W., Ludolph A. C. Chemical preconditioning: a cytoprotective strategy. Mol Cell Biochem. 1997 Sep;174(1-2):249–254. [PubMed] [Google Scholar]
  28. Sheikh-Hamad D., Timmins K., Jalali Z. Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol. 1997 Oct;8(10):1640–1644. doi: 10.1681/ASN.V8101640. [DOI] [PubMed] [Google Scholar]
  29. Somani S. M., Husain K., Whitworth C., Trammell G. L., Malafa M., Rybak L. P. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol. 2000 May;86(5):234–241. doi: 10.1034/j.1600-0773.2000.d01-41.x. [DOI] [PubMed] [Google Scholar]
  30. Tsutsumishita Y., Onda T., Okada K., Takeda M., Endou H., Futaki S., Niwa M. Involvement of H2O2 production in cisplatin-induced nephrotoxicity. Biochem Biophys Res Commun. 1998 Jan 14;242(2):310–312. doi: 10.1006/bbrc.1997.7962. [DOI] [PubMed] [Google Scholar]
  31. Whiteside C., Hassan H. M. Induction and inactivation of catalase and superoxide dismutase of Escherichia coli by ozone. Arch Biochem Biophys. 1987 Sep;257(2):464–471. doi: 10.1016/0003-9861(87)90591-1. [DOI] [PubMed] [Google Scholar]
  32. Winston J. A., Safirstein R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol. 1985 Oct;249(4 Pt 2):F490–F496. doi: 10.1152/ajprenal.1985.249.4.F490. [DOI] [PubMed] [Google Scholar]
  33. Zhang J. G., Lindup W. E. Cisplatin nephrotoxicity: decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem Pharmacol. 1994 Mar 29;47(7):1127–1135. doi: 10.1016/0006-2952(94)90383-2. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES